Xylem (XYL) earnings history
Most recent quarter
- Fiscal period
- Q3 2026
- Period end
- Sep 30, 2026
- EPS actual
- $1.44
- EPS estimate
- $1.45
- EPS surprise
- −0.65%
- Revenue surprise
- −3.46%
- Revenue
- $2.2B
- Revenue estimate
- $2.3B
- Reported
- Oct 27, 2026
Xylem reported Q3 2026 results on October 27, 2026. EPS was $1.44, just short of the $1.45 estimate by 0.65%. Revenue was $2.20 billion, below the $2.28 billion estimate. Compared with Q3 2025, EPS rose about 5.1% from $1.37, while revenue fell about 3% from $2.27 billion. Both were down from Q2 2026, when EPS was $1.46 and revenue $2.34 billion.
The longer record shows steady growth. Annual EPS rose each year, from $2.84 in 2022 to $3.68 in 2023, $4.28 in 2024 and $5.08 in 2025. Annual revenue grew from $5.5 billion in 2022 to $7.4 billion in 2023, $8.6 billion in 2024 and $9.0 billion in 2025. The first three quarters of 2026 add up to $4.02 per share, about 10% more than the $3.66 a year earlier, on nearly unchanged revenue. Over the last 20 quarters, EPS ranged from $0.47 in Q1 2022 to $1.46 in Q2 2026. Xylem beat the EPS estimate 19 times, and Q3 2026 was the only miss.
Xylem reported Q4 results between February 3 and February 10 in each of the past five years. That points to early February 2027 for the Q4 2026 report. It will complete fiscal 2026.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q3 2026 | Oct 27, 2026 | $1.45 | $1.44 | −0.65% | $2.2B | SEC |
| Q2 2026 | Jul 28, 2026 | $1.34 | $1.46 | +9.18% | $2.3B | SEC |
| Q1 2026 | Apr 28, 2026 | $1.08 | $1.12 | +3.24% | $2.1B | SEC |
| Q4 2025 | Feb 10, 2026 | $1.41 | $1.42 | +0.82% | $2.4B | SEC |
| Q3 2025 | Oct 28, 2025 | $1.23 | $1.37 | +11.12% | $2.3B | SEC |
| Q2 2025 | Jul 31, 2025 | $1.15 | $1.26 | +9.74% | $2.3B | SEC |
| Q1 2025 | Apr 29, 2025 | $0.95 | $1.03 | +7.86% | $2.1B | SEC |
| Q4 2024 | Feb 4, 2025 | $1.12 | $1.18 | +4.90% | $2.3B | SEC |
| Q3 2024 | Oct 31, 2024 | $1.11 | $1.11 | +0.07% | $2.1B | SEC |
| Q2 2024 | Jul 30, 2024 | $1.05 | $1.09 | +3.63% | $2.2B | SEC |
| Q1 2024 | May 2, 2024 | $0.84 | $0.90 | +7.33% | $2.0B | SEC |
| Q4 2023 | Feb 6, 2024 | $0.96 | $0.99 | +3.61% | $2.1B | SEC |
| Q3 2023 | Oct 31, 2023 | $0.89 | $0.99 | +11.75% | $2.1B | SEC |
| Q2 2023 | Aug 2, 2023 | $0.82 | $0.98 | +20.08% | $1.7B | SEC |
| Q1 2023 | May 4, 2023 | $0.62 | $0.72 | +16.47% | $1.4B | SEC |
| Q4 2022 | Feb 7, 2023 | $0.79 | $0.92 | +16.03% | $1.5B | SEC |
| Q3 2022 | Nov 1, 2022 | $0.66 | $0.79 | +19.77% | $1.4B | SEC |
| Q2 2022 | Aug 2, 2022 | $0.54 | $0.66 | +22.77% | $1.4B | SEC |
| Q1 2022 | May 4, 2022 | $0.41 | $0.47 | +14.27% | $1.3B | SEC |
| Q4 2021 | Feb 3, 2022 | $0.61 | $0.63 | +2.69% | $1.3B | SEC |
Quarterly revenue
Frequently asked questions
When did Xylem (XYL) last report earnings?
Xylem last reported on Oct 27, 2026, covering fiscal Q3 2026.
Did XYL beat earnings estimates?
No. Xylem reported EPS of $1.44 for Q3 2026 against a $1.45 estimate — a 0.65% miss.
How much revenue did XYL report last quarter?
Xylem reported $2.2B in revenue for Q3 2026, against a consensus estimate of $2.3B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

